2021 was certainly a challenging year for many  but for Clindox it was positive and memorable

With the pandemic and resulting uncertainty continuing to impact throughout this year, it’s been a challenging 2021 for businesses across the world. Despite disruption to trials and to our clients’ plans and challenging and constantly changing working environments,  Clindox experienced significant growth and recorded its most successful year to date. Here are the highlights:

• Doubling of turnover across key geographic markets of Europe, Israel and India.

• 30% growth in the Clindox team to meet the increased demand and workload including new additions to the R&D, Customer Success, Sales and Finance teams.

• Major product release incorporating a brand new cutting edge UI for CRFWEB with numerous product improvements to support an extremely user-friendly and attractive user interface.

We have some really exciting new product releases scheduled for Q1 of 2022 and look forward to letting you know about them in the new year.

In addition to product news, we’ve created a steady stream of market-relevant and topical articles throughout this year and added informative content to our website through our dedicated resource centre.  We will continue to do so, making our site the go to platform for all things eClinical in the Medical Device Sector.

We wish everyone a safe and enjoyable festive season and look forward to working with you in 2022 to optimise the processes that bring medical devices to the people that need them faster.